Overview

Exparel for Pain Control During Care of Rib Fractures

Status:
Withdrawn
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This study is looking at a novel therapy of numbing medication injected directly around the fracture site. The purpose of this study is to determine if the study medication, EXPAREL®, is a viable alternative to current therapies for rib fractures.
Phase:
Phase 4
Details
Lead Sponsor:
Michael Moncure, MD
Treatments:
Bupivacaine